clinical trial endpoint

Staffaroni, Adam M.; Bajorek, Lynn; Casaletto, Kaitlin B.; Cobigo, Yann; Goh, Sheng-Yang M.; Wolf, Amy; Heuer, Hilary W.; Elahi, Fanny M.; Ljubenkov, Peter A.; Dever, Reilly; Kornak, John; Appleby, Brian; Bove, Jessica; Bordelon, Yvette; Brannelly, Patrick; Brushaber, Danielle; Caso, Christina; Coppola, Giovanni; Dheel, Christina; Dickerson, Bradford C.; Dickinson, Susan; Dominguez, Sophia; Domoto-Reilly, Kimiko; Faber, Kelly; Ferrall, Jessica; Fields, Julie A.; Fishman, Ann; Fong, Jamie; Foroud, Tatiana; Forsberg, Leah K.; Gavrilova, Ralitza; Gearhart, Debra; Ghazanfari, Behnaz; Ghoshal, Nupur; Goldman, Jill; Graff-Radford, Jonathan; Graff-Radford, Neill; Grant, Ian; Grossman, Murray; Haley, Dana; Hsiung, Ging-Yuek; Huey, Edward D.; Irwin, David J.; Jones, David T.; Jones, Lynne; Kantarci, Kejal; Karydas, Anna; Kaufer, Daniel I.; Kerwin, Diana R.; Knopman, David S.; Kraft, Ruth; Kremers, Walter K.; Kukull, Walter A.; Litvan, Irene; Lucente, Diane; Lungu, Codrin; Mackenzie, Ian R.; Maldonado, Miranda; Manoochehri, Masood; McGinnis, Scott M.; McKinley, Emily; Mendez, Mario F.; Miller, Bruce L.; Multani, Namita; Onyike, Chiadi; Padmanabhan, Jaya; Pantelyat, Alex; Pearlman, Rodney; Petrucelli, Len; Potter, Madeline; Rademakers, Rosa; Ramos, Eliana Marisa; Rankin, Katherine P.; Rascovsky, Katya; Roberson, Erik D.; Rogalski, Emily; Sengdy, Pheth; Shaw, Leslie M.; Syrjanen, Jeremy; Tartaglia, M. Carmela; Tatton, Nadine; Taylor, Joanne; Toga, Arthur; Trojanowski, John Q.; Weintraub, Sandra; Wang, Ping; Wong, Bonnie; Wszolek, Zbigniew; Boxer, Adam L.; Boeve, Brad F.; Kramer, Joel H.; Rosen, Howard J.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

clinical trial endpoint

Published Date:

January 2020

Source:

Alzheimers Dement. 16(1):11-21

Language:

English

Public Access Version Available on: January 01, 2021, 12:00 AM

Please check back on the date listed above.

Details:

Alternative Title:

Alzheimers Dement

Personal Author:

Staffaroni, Adam M. ; Bajorek, Lynn ; Casaletto, Kaitlin B. ; Cobigo, Yann ; Goh, Sheng-Yang M. ; ... More ▼

Description:

Introduction: Identifying clinical measures that track disease in the earliest stages of frontotemporal lobar degeneration (FTLD) is important for clinical trials. Familial FTLD provides a unique paradigm to study early FTLD. Executive dysfunction is a clinically relevant hallmark of FTLD and may be a marker of disease progression. Methods: Ninety-three mutation carriers with no symptoms or minimal/questionable symptoms (MAPT, n = 31; GRN,n = 28; C9orf72,n = 34; Clinical Dementia Rating scale plus NACC FTLD Module <1) and 78 noncarriers enrolled through Advancing Research and Treatment in Frontotemporal Lobar Degeneration/Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects studies completed the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH-EXAMINER) and the UDS neuropsychological battery. Linear mixed-effects models were used to identify group differences in cognition at baseline and longitudinally. We examined associations between cognition, clinical functioning, and magnetic resonance imaging volumes. Results: NIH-EXAMINER scores detected baseline and differences in slopes between carriers and noncarriers, even in carriers with a baseline Clinical Dementia Rating scale plus NACC FTLD Module = 0. NIH-EXAMINER declines were associated with worsening clinical symptoms and brain volume loss. Discussion: The NIH-EXAMINER is sensitive to cognitive changes in presymptomatic familial FTLD and is a promising surrogate endpoint.

Subject:

[+]

Pubmed ID:

31914230

Pubmed Central ID:

PMC6842665

Document Type:

Journal Article

Funding:

Biogen/International ; K24 AG045333/AG/NIA NIH HHS/United States ; U24 AG021886/AG/NIA NIH HHS/United States ; P01 AG017586/AG/NIA NIH HHS/United States ; Genentech/International ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Race, ethnicity, and age trends in persons who died from COVID-19 — United States, May–August 2020

Personal Author:

Gold, Jeremy A. W.; Rossen, Lauren M.; Ahmad, Farida B.; Sutton, Paul; Li, Zeyu; Salvatore, Phillip P.; Coyle, Jayme P.; DeCuir, Jennifer; Baack, Brittney N.; Durant, Tonji M.; Dominguez, Kenneth L.; Henley, S. Jane; Annor, Francis B.; Fuld, Jennifer; Dee, Deborah L.; Bhattarai, Achuyt; Jackson, Brendan R.;

Corporate Authors:

CDC COVID-9 Emergency Response.. Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service.. National Center for Health Statistics (U.S.). NYC Health + Hospitals..

Published Date:

October 16, 2020

Source:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 16, 2020

Series:

37

Description:

What is already known about this topic? Persons aged ≥65 years and members of minority racial and ethnic groups are disproportionately represented among COVID-19–associated deaths.What is added by this report? Analysis of 114,411 COVID-19–assoc...

File Type:

[PDF - 217.52 KB]
COVID-19 forecasts : hospitalizations [National Forecast]

Corporate Authors:

Centers for Disease Control and Preventin (U.S.)

Published Date:

2020-10-12

Description:

• The national forecasts show the predicted number of new COVID-19 hospitalizations per day for the next four weeks in the United States.• The forecasts make different assumptions about hospitalization rates and levels of social distancing and ot...

File Type:

[JPEG - 72.27 KB]
Transmission dynamics by age group in COVID-19 hotspot counties — United States, April–September 2020

Personal Author:

Oster, Alexandra M.; Caruso, Elise; DeVies, Jourdan; Hartnett, Kathleen P.; Boehmer, Tegan K.;

Corporate Authors:

CDC COVID-9 Response Team.

Published Date:

October 9, 2020

Series:

MMWR. Morbidity and mortality weekly report ; v. 69, early release, October 9, 2020

Description:

CDC works with other federal agencies to identify counties with increasing coronavirus disease 2019 (COVID-19) incidence (hotspots) and offers support to state, tribal, local, and territorial health departments to limit the spread of SARS-CoV-2, the ...

File Type:

[PDF - 153.89 KB]
COVID-19 science update ; Edition 2020-10-06

Corporate Authors:

Centers for Disease Control and Prevention (U.S.).Office of the Chief Medical Officer.. CDC COVID-19 Response.. Centers for Disease Control and Prevention (U.S.). Stephen B. Thacker CDC Library.

Published Date:

October 6, 2020

Series:

COVID-19 science update ; Edition 2020-10-06

Description:

From the Office of the Chief Medical Officer, CDC COVID-19 Response, and the CDC Library, Atlanta GA. Intended for use by public health professionals responding to the COVID-19 pandemic.Disclaimer: The purpose of the CDC COVID-19 Science Update is to...

File Type:

[PDF - 2.39 MB]
COVID-19 forecasts : hospitalizations [National Forecast]

Corporate Authors:

Centers for Disease Control and Preventin (U.S.)

Published Date:

2020-10-05

Description:

• The seven national forecasts show the predicted number of new COVID-19 hospitalizations per day for the next four weeks in the United States.• The forecasts make different assumptions about hospitalization rates and levels of social distancing ...

File Type:

[JPEG - 146.59 KB]